Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive examination. Proponents often stress the possibility for meaningful therapeutic benefits, particularly in diseases where conventional medications have proven limited. However, this is to assess the substantial financial burden associated with CPI stem cell the